Management of Hashimoto's Thyroiditis

Clinical Decision-Making

• The American College of Physicians, as reported in JAMA, recommends focusing on thyroid function tests (TSH, free T4) rather than antibody titers for clinical decision-making 2
• The guideline society Praxis Medical Insights recommends that the absolute antibody level is less important than monitoring thyroid function (TSH and free T4) every 6-12 months 1
• Patients with positive thyroid antibodies have a 4.3% annual risk of progressing to overt hypothyroidism, regardless of antibody fluctuations, according to Praxis Medical Insights 1

Monitoring and Treatment

• Praxis Medical Insights suggests repeating thyroid function tests at 6-12 month intervals to monitor for TSH elevation, not antibody levels 1
• Treatment with levothyroxine is indicated when TSH exceeds 10 mIU/L or if symptomatic hypothyroidism develops, independent of antibody titers, as recommended by Praxis Medical Insights 1
• The JAMA guideline advises against adjusting treatment based on antibody fluctuations alone—thyroid function tests determine management 2